NM_022095.4:c.4021G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022095.4(ZNF335):c.4021G>A(p.Asp1341Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022095.4 missense
Scores
Clinical Significance
Conservation
Publications
- microcephalic primordial dwarfism due to ZNF335 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF335 | NM_022095.4 | c.4021G>A | p.Asp1341Asn | missense_variant | Exon 28 of 28 | ENST00000322927.3 | NP_071378.1 | |
ZNF335 | XM_047440363.1 | c.4021G>A | p.Asp1341Asn | missense_variant | Exon 27 of 27 | XP_047296319.1 | ||
ZNF335 | XM_005260504.5 | c.4018G>A | p.Asp1340Asn | missense_variant | Exon 27 of 27 | XP_005260561.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152198Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251190 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461568Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727102 show subpopulations
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74478 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.4021G>A (p.D1341N) alteration is located in exon 28 (coding exon 27) of the ZNF335 gene. This alteration results from a G to A substitution at nucleotide position 4021, causing the aspartic acid (D) at amino acid position 1341 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at